WHO Includes GLP-1 Weight Loss and Diabetes Drugs in Essential Medicines List
TL;DR Summary
The WHO has added GLP-1 drugs for diabetes to its essential medicines list to improve global access, highlighting their importance despite high costs, and encouraging generic production to increase affordability. The list also includes treatments for cystic fibrosis and cancer, aiming to enhance availability worldwide.
- WHO adds GLP-1 drugs for diabetes, others to essential medicines list Reuters
- WHO updates list of essential medicines to include key cancer, diabetes treatments World Health Organization (WHO)
- WHO adds weight-loss, diabetes drugs to essential medicines list Al Jazeera
- WHO Adds Ozempic and Mounjaro to Its List of Essential Medicines Bloomberg.com
- WHO adds GLP-1 weight loss drugs to list of the world's essential medicines for the first time Quartz
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
93%
652 → 45 words
Want the full story? Read the original article
Read on Reuters